Clinical Trials · NCT06182891
Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Enrollment
- 300
- Start date
- Oct 2021
- Locations
- 1 site, China
- Primary endpoint
- Evaluation of the urinary albumin-to-creatinine ratio